These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 23189411

  • 21. [Drugs for hepatitis B and C infection].
    Iino S.
    Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():391-5. PubMed ID: 17455651
    [No Abstract] [Full Text] [Related]

  • 22. Ribavirin and interferon for recurrent posttransplantation HCV infection: to treat or not to treat?
    McHutchison JG.
    Hepatology; 1997 Aug 28; 26(2):505-6. PubMed ID: 9252167
    [No Abstract] [Full Text] [Related]

  • 23. [Boceprevir (Victrelis), oral administration].
    J Pharm Belg; 2012 Jun 28; (2):37-9. PubMed ID: 22978014
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of chronic hepatitis C: present and future].
    Hezode C, Dhumeaux D.
    Gastroenterol Clin Biol; 2000 May 28; 24(5):533-5. PubMed ID: 10891741
    [No Abstract] [Full Text] [Related]

  • 25. A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens.
    Broglio KR, Daar ES, Quintana M, Yuan Y, Kalsekar A, Spellberg B, Lewis RJ, Akker Dv, Detry MA, Le T, Berry SM.
    J Comp Eff Res; 2015 Mar 28; 4(2):101-14. PubMed ID: 25825840
    [Abstract] [Full Text] [Related]

  • 26. [Triple therapy in the treatment of hepatitis C].
    Fernández-Castroagudín J, Molina-Pérez E.
    Rev Esp Enferm Dig; 2013 Mar 28; 105(10):634. PubMed ID: 24641463
    [No Abstract] [Full Text] [Related]

  • 27. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
    Dou XG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul 28; 17(7):486-7. PubMed ID: 19912678
    [No Abstract] [Full Text] [Related]

  • 28. Analysis of ribavirin mutagenicity in human hepatitis C virus infection.
    Chevaliez S, Brillet R, Lázaro E, Hézode C, Pawlotsky JM.
    J Virol; 2007 Jul 28; 81(14):7732-41. PubMed ID: 17494069
    [Abstract] [Full Text] [Related]

  • 29. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
    Lange CM, Sarrazin C, Zeuzem S.
    Pharm Unserer Zeit; 2011 Jan 28; 40(1):60-7. PubMed ID: 21194084
    [No Abstract] [Full Text] [Related]

  • 30. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R, Planas Vilà R, Durández Lazaro R, Fábregas Puigtió S.
    Gastroenterol Hepatol; 2002 Oct 28; 25(8):483-6. PubMed ID: 12361528
    [Abstract] [Full Text] [Related]

  • 31. [Treatment for chronic hepatitis C, more opportunity, more challenge].
    Wei L.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul 28; 17(7):481-3. PubMed ID: 19912676
    [No Abstract] [Full Text] [Related]

  • 32. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong.
    Yuen MF, Lai CL.
    Intervirology; 2006 Jul 28; 49(1-2):96-8. PubMed ID: 16166796
    [Abstract] [Full Text] [Related]

  • 33. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M, Fernández Lucas M, Echarri R, Teruel JL, Alarcón C, Merino JL, Ortuño J.
    Nefrologia; 2004 Jul 28; 24 Suppl 3():39-42. PubMed ID: 15219067
    [Abstract] [Full Text] [Related]

  • 34. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V, Rousseau A, Marquet P, Denis F, Alain S.
    Expert Rev Anti Infect Ther; 2009 Apr 28; 7(3):249-53. PubMed ID: 19344238
    [No Abstract] [Full Text] [Related]

  • 35. [Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].
    Ignatova TM, Mukhin NA.
    Ter Arkh; 2012 Apr 28; 84(11):81-8. PubMed ID: 23252255
    [Abstract] [Full Text] [Related]

  • 36. [Victrelis and Incivek against hepatitis C: some promising options].
    Sabourin G.
    Perspect Infirm; 2012 Apr 28; 9(1):58-9. PubMed ID: 22295460
    [No Abstract] [Full Text] [Related]

  • 37. Marketing scam spoils hep C treatment.
    Proj Inf Perspect; 1998 Dec 28; (26):6. PubMed ID: 11366498
    [Abstract] [Full Text] [Related]

  • 38. Acute hepatitis C treatment.
    Lerias de Almeida PR.
    Ann Hepatol; 2010 Dec 28; 9 Suppl():107-11. PubMed ID: 20714006
    [Abstract] [Full Text] [Related]

  • 39. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A, Yong JF, Zulkifli HI, Jamal R.
    Med J Malaysia; 2002 Sep 28; 57(3):353-6. PubMed ID: 12440276
    [Abstract] [Full Text] [Related]

  • 40. Needle-stick exposure in the health care setting: do not forget hepatitis C!
    Hoepelman AI.
    Neth J Med; 2000 Jul 28; 57(1):4-6. PubMed ID: 10862995
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.